This Market Spotlight report covers the Polycystic Ovary Syndrome
market, comprising key pipeline and marketed drugs, clinical trials, patent information, and a 10-year disease prevalence forecast, as well as licensing and acquisition deals.
The role of polycystic ovary syndrome
in reproductive and metabolic health: Overview and approaches for treatment.
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome
. Best Pract Res Clin Endocrinol Metab.
The prevalence and features of the polycystic ovary syndrome
in an unselected population.
Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome
. Diabetes Care 2010;33:887-93.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
Prevalence of polycystic ovary syndrome
in Chinese obese women of reproductive age with or without metabolic syndrome.
Polycystic Ovary Syndrome
(PCOS) is a major cause of infertility affecting 6-10% of the female population.1 Phenotypes are variable, characterized by polycystic ovaries, hyperandrogenism, obesity, ovulatory dysfunction, fecund ability and early pregnancy loss.
Omega-3 supplementation effects on polycystic ovary syndrome
symptoms and metabolic syndrome.
WOMEN with polycystic ovary syndrome
(PCOS) are prone to mental health disorders, a new study by a Welsh university has revealed.
Question: What is Polycystic Ovary Syndrome
and How do I Know if I Have it?
Previous research has also suggested a link between air pollution and infertility and other issues in the female reproductive system, like the hormonal condition (https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome) polycystic ovary syndrome